Key result
Captopril, olmesartan, melatonin, and compound 21 significantly prevented the doxorubicin-induced reduction of glomerular density and diminished oxidative stress in rats.
Why the study?
Do captopril, olmesartan, melatonin, and compound 21 prevent doxorubicin-induced nephrotoxicity in rats?
Do captopril, olmesartan, melatonin, and compound 21 prevent doxorubicin-induced nephrotoxicity in rats?
Captopril, olmesartan, melatonin, and compound 21 demonstrated similar renoprotective effects against doxorubicin-induced nephrotoxicity in a rat model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rat doxorubicin nephrotoxicity; human trials needed before any clinical consideration.
Chronic kidney disease (CKD) represents a serious public health problem with increasing prevalence and novel approaches to renal protection are continuously under investigation. The aim of this study was to compare the effect of melatonin and angiotensin II type 2 receptor agonist compound 21 (C21) to angiotensin converting enzyme inhibitor captopril and angiotensin II type 1 receptor blocker olmesartan on animal model of doxorubicin nephrotoxicity. Six groups of 3-month-old male Wistar rats (12 per group) were treated for four weeks. The first group served as a control. The remaining groups were injected with a single dose of doxorubicin (5 mg/kg i.v.) at the same day as administration of either vehicle or captopril (100 mg/kg/day) or olmesartan (10 mg/kg/day) or melatonin (10 mg/kg/day) or C21 (0.3 mg/kg/day) was initiated. After four week treatment, the blood pressure and the level of oxidative stress were enhanced along with reduced glomerular density and increased glomerular size. Captopril, olmesartan and melatonin prevented the doxorubicin-induced increase in systolic blood pressure. All four substances significantly diminished the level of oxidative burden and prevented the reduction of glomerular density and modestly prevented the increase of glomerular size. We conclude that captopril, olmesartan, melatonin and C21 exerted a similar level of renoprotective effects in doxorubicin-induced nephrotoxicity.
No takes yet. Share an insight, caveat, or question.
Hrenak et al. (2013) studied Doxorubicin-induced nephrotoxicity (n=72). Captopril, olmesartan, melatonin, and compound 21 vs. Vehicle (doxorubicin control) was evaluated on Glomerular numerical density per area (p=<0.05). Captopril, olmesartan, melatonin, and compound 21 significantly prevented the doxorubicin-induced reduction of glomerular density and diminished oxidative stress in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: